ESM1 and hydrops fetalis: Our results suggest that endocan levels are associated with adverse prognosis in chronic HF, with every increase in endocan levels for 1 ng/mL being associated with a ~1,5-fold increase in HF-related events in patients deemed clinically stable and optimally managed.